Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01616797 · ClinicalTrials.gov registry record · NA
A Novel Neurobehavioral Intervention for Emotion Regulation in Anxiety and Depression Across the Lifespan
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
NCT01616797: Completed NA study, sponsored by Stanford University.
NCT01616797 is a NA study that has completed, run by Stanford University. The registered enrollment target is 68 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01616797, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
Study Summary
The research proposes to use an innovative solution to shape brain circuits that support executive function and emotion reactivity -using targeted neurobehavioral intervention.
Primary Outcome
We anticipate that participants will complete at least 30-days of the intervention.
Interventions
- BEHAVIORAL Computerized neurobehavioral intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2014-02 |
| Est. Completion | 2018-08 |
| Phase | NA |
What the finished NCT01616797 record still lists
NCT01616797 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Computerized neurobehavioral intervention is the first listed.
NCT01616797 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01616797 about?
NCT01616797 is a clinical study titled "A Novel Neurobehavioral Intervention for Emotion Regulation in Anxiety and Depression Across the Lifespan". The research proposes to use an innovative solution to shape brain circuits that support executive function and emotion reactivity -using targeted neurobehavioral intervention.
What is the current status of trial NCT01616797?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2014-02. Estimated completion is 2018-08.
What interventions are being tested in trial NCT01616797?
The interventions under investigation include: Computerized neurobehavioral intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01616797?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01616797's enrollment target sits among peer trials
68 1133rd of 2000 higher than 862 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia